✦ LIBER ✦

Efficacy and Safety of the Selective Aldosterone Blocker Eplerenone in Japanese Patients With Hypertension: A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study

✍ Scribed by Takao Saruta; Shigeru Kageyama; Toshio Ogihara; Kunio Hiwada; Masayo Ogawa; Kazuji Tawara; Marjorie Gatlin; Susan Garthwaite; Richard Bittman; Jeffrey Patrick

Book ID: 115306041
Publisher: Le Jacq Communications, Inc.
Year: 2004
Tongue: English
Weight: 322 KB
Volume: 6
Category: Article
ISSN: 1524-6175
DOI: 10.1111/j.1524-6175.2004.03146.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and Safety of Darusentan in Pat

Efficacy and Safety of Darusentan in Patients With Resistant Hypertension: Results From a Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study

✍ Henry R. Black; George L. Bakris; Michael A. Weber; Robert Weiss; Mahfouz El Sha 📂 Article 📅 2007 🏛 Le Jacq Communications, Inc. 🌐 English ⚖ 246 KB

The Efficacy and Safety of the Novel Ald

The Efficacy and Safety of the Novel Aldosterone Antagonist Eplerenone in Children with Hypertension: A Randomized, Double-Blind, Dose-Response Study

✍ Jennifer S. Li; Joseph T. Flynn; Ronald Portman; Ira Davis; Masayo Ogawa; Harry 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 214 KB

Dose-dependent Safety and Efficacy of Zo

Dose-dependent Safety and Efficacy of Zonisamide: A Randomized, Double-blind, Placebo-controlled Study in Patients with Refractory Partial Seizures

✍ Martin J. Brodie; Roderick Duncan; Herve Vespignani; Andras Solyom; Valeriy Bite 📂 Article 📅 2005 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 170 KB

Efficacy and safety of pramipexole in Ja

Efficacy and safety of pramipexole in Japanese patients with primary restless legs syndrome: A polysomnographic randomized, double-blind, placebo-controlled study

✍ Yuichi Inoue; Koichi Hirata; Kenji Kuroda; Masahiko Fujita; Tetsuo Shimizu; Naru 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 212 KB

A double-blind, placebo-controlled, dose

A double-blind, placebo-controlled, dose escalation safety, and efficacy study of ziac in patients, ages 6–17 years, with hypertension

✍ R.J. Cunningham; E.M. Urbina; R.J. Hogg; J.M. Sorof; M. Moxey-Mimms; M.A. Eissa 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 155 KB

A Randomized, Double-Blind, Placebo-Cont

A Randomized, Double-Blind, Placebo-Controlled Parallel-Group Study to Assess the Efficacy and Safety of Nebivolol, a Novel β-Blocker, in Patients With Mild to Moderate Hypertension

✍ Robert J. Weiss; Michael A. Weber; Albert A. Carr; Will A. Sullivan 📂 Article 📅 2007 🏛 Le Jacq Communications, Inc. 🌐 English ⚖ 218 KB